Memphasys Ltd has released a press release.
MEM Successfully trials RoXsta Mega Cell High-Throughput
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- $1.275M Placement to Accelerate Commercial Rollout
- Pause in Trading
- RoXsta offers Effective Oxidative Stress Measurem't 4 Cattle
- Felix Trial Confirms Best-in-Class Performance
- Half Yearly Report and Accounts
Later from Memphasys
- CE Mark Lodged for Felix to Expand Global Access
- Presentation to Shareholders at General Meeting
- Preliminary Final Report
- FELIX landmark commercial agreement signed for MENA region
- Memphasys Secures Significant ITL Contract Upgrade
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys